Veeva Systems - VEEV Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $234.90
  • Forecasted Upside: 17.73%
  • Number of Analysts: 20
  • Breakdown:
  • 1 Sell Ratings
  • 5 Hold Ratings
  • 14 Buy Ratings
  • 0 Strong Buy Ratings
$199.52
▲ +0.32 (0.16%)

This chart shows the closing price for VEEV by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Veeva Systems Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VEEV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VEEV

Analyst Price Target is $234.90
▲ +17.73% Upside Potential
This price target is based on 20 analysts offering 12 month price targets for Veeva Systems in the last 3 months. The average price target is $234.90, with a high forecast of $270.00 and a low forecast of $160.00. The average price target represents a 17.73% upside from the last price of $199.52.

This chart shows the closing price for VEEV for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 20 investment analysts is to moderate buy stock in Veeva Systems. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 14 buy ratings
  • 5 hold ratings
  • 1 sell ratings
10/26/2022
  • 0 strong buy ratings
  • 14 buy ratings
  • 5 hold ratings
  • 1 sell ratings
1/24/2023
  • 0 strong buy ratings
  • 14 buy ratings
  • 5 hold ratings
  • 1 sell ratings
4/24/2023
  • 0 strong buy ratings
  • 14 buy ratings
  • 5 hold ratings
  • 1 sell ratings
7/23/2023
  • 0 strong buy ratings
  • 14 buy ratings
  • 5 hold ratings
  • 1 sell ratings
10/21/2023
  • 0 strong buy ratings
  • 14 buy ratings
  • 5 hold ratings
  • 1 sell ratings
1/19/2024
  • 0 strong buy ratings
  • 14 buy ratings
  • 5 hold ratings
  • 1 sell ratings
3/19/2024
  • 0 strong buy ratings
  • 14 buy ratings
  • 5 hold ratings
  • 1 sell ratings
4/18/2024

Latest Recommendations

  • 0 strong buy ratings
  • 14 buy ratings
  • 5 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/2/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$260.00Low
3/27/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$250.00Low
3/26/2024Raymond JamesReiterated RatingOutperform ➝ Outperform$260.00Low
3/13/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$183.00 ➝ $222.00Low
3/5/2024KeyCorpBoost TargetOverweight ➝ Overweight$232.00 ➝ $250.00Low
3/4/2024Jefferies Financial GroupBoost TargetBuy ➝ Buy$225.00 ➝ $270.00Low
3/1/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$245.00 ➝ $251.00Low
3/1/2024CitigroupBoost TargetBuy ➝ Buy$240.00 ➝ $264.00Low
3/1/2024The Goldman Sachs GroupBoost TargetBuy ➝ Buy$219.00 ➝ $248.00Low
3/1/2024Stifel NicolausBoost TargetBuy ➝ Buy$205.00 ➝ $250.00Low
3/1/2024Truist FinancialBoost TargetHold ➝ Hold$187.00 ➝ $203.00Low
3/1/2024Piper SandlerBoost TargetOverweight ➝ Overweight$220.00 ➝ $245.00Low
3/1/2024BarclaysBoost TargetOverweight ➝ Overweight$240.00 ➝ $245.00Low
3/1/2024Needham & Company LLCBoost TargetBuy ➝ Buy$220.00 ➝ $260.00Low
2/26/2024UBS GroupBoost TargetNeutral ➝ Neutral$185.00 ➝ $235.00Low
2/23/2024BarclaysBoost TargetOverweight ➝ Overweight$220.00 ➝ $240.00Low
2/22/2024OppenheimerReiterated RatingOutperform ➝ Outperform$225.00Low
1/24/2024KeyCorpBoost TargetOverweight ➝ Overweight$210.00 ➝ $232.00Low
1/16/2024Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$225.00 ➝ $250.00Low
1/2/2024Piper SandlerBoost TargetOverweight ➝ Overweight$200.00 ➝ $220.00Low
12/8/2023KeyCorpLower TargetOverweight ➝ Overweight$230.00 ➝ $210.00Low
12/7/2023Stifel NicolausReiterated RatingBuy ➝ Buy$205.00Low
12/7/2023Canaccord Genuity GroupLower TargetHold ➝ Hold$210.00 ➝ $185.00Low
12/7/2023Piper SandlerReiterated RatingOverweight ➝ Overweight$200.00Low
12/7/2023Needham & Company LLCReiterated RatingBuy ➝ Buy$220.00Low
12/7/2023BarclaysLower TargetOverweight ➝ Overweight$220.00 ➝ $213.00Low
11/29/2023JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$188.00 ➝ $183.00Low
11/13/2023Truist FinancialReiterated RatingHold ➝ Hold$227.00Low
11/13/2023The Goldman Sachs GroupLower TargetBuy ➝ Buy$244.00 ➝ $216.00Low
11/13/2023Morgan StanleyLower TargetUnderweight ➝ Underweight$181.00 ➝ $160.00Low
11/10/2023Piper SandlerLower TargetOverweight ➝ Overweight$235.00 ➝ $200.00Low
11/10/2023Needham & Company LLCReiterated RatingBuy ➝ Buy$220.00Low
11/10/2023Raymond JamesLower TargetOutperform ➝ Outperform$240.00 ➝ $200.00Low
10/25/2023Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$211.00 ➝ $229.00Low
10/13/2023Jefferies Financial GroupInitiated CoverageBuy$265.00Low
10/11/2023KeyCorpBoost TargetOverweight ➝ Overweight$220.00 ➝ $230.00Low
9/14/2023Robert W. BairdReiterated RatingOutperform ➝ Outperform$242.00Low
9/13/2023BarclaysBoost TargetOverweight ➝ Overweight$227.00 ➝ $250.00Low
9/7/2023Truist FinancialBoost TargetHold ➝ Hold$204.00 ➝ $227.00Low
9/5/2023Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$180.00 ➝ $211.00Low
8/31/2023Bank of AmericaBoost TargetNeutral ➝ Neutral$200.00 ➝ $220.00Low
8/31/2023Needham & Company LLCReiterated RatingBuy ➝ Buy$220.00Low
8/31/2023OppenheimerReiterated RatingOutperform ➝ Outperform$225.00Low
8/31/2023Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$225.00Low
8/31/2023Stifel NicolausBoost TargetBuy ➝ Buy$205.00 ➝ $211.00Low
8/31/2023Canaccord Genuity GroupBoost TargetHold ➝ Hold$170.00 ➝ $210.00Low
8/31/2023Raymond JamesBoost TargetOutperform ➝ Outperform$210.00 ➝ $240.00Low
8/31/2023Piper SandlerBoost TargetOverweight ➝ Overweight$232.00 ➝ $235.00Low
8/31/2023UBS GroupBoost TargetNeutral ➝ Neutral$175.00 ➝ $205.00Low
8/31/2023Robert W. BairdBoost TargetOutperform ➝ Outperform$235.00 ➝ $242.00Low
8/31/2023BarclaysBoost TargetOverweight ➝ Overweight$225.00 ➝ $228.00Low
8/28/2023CitigroupBoost TargetBuy ➝ Buy$210.00 ➝ $236.00Low
7/31/2023Piper SandlerBoost TargetOverweight$215.00 ➝ $232.00Low
6/30/2023Robert W. BairdReiterated RatingOutperform ➝ Outperform$235.00Low
6/28/2023Morgan StanleyDowngradeEqual Weight ➝ Underweight$181.00Low
6/23/2023BarclaysBoost Target$203.00 ➝ $225.00Low
6/8/2023Truist FinancialBoost Target$195.00 ➝ $204.00Low
6/2/2023KeyCorpBoost Target$185.00 ➝ $210.00Low
6/1/2023Piper SandlerBoost Target$212.00 ➝ $215.00Low
6/1/2023Raymond JamesBoost Target$200.00 ➝ $210.00Low
6/1/2023Robert W. BairdBoost Target$227.00 ➝ $235.00Low
6/1/2023GuggenheimUpgradeNeutral ➝ Buy$226.00Low
6/1/2023BarclaysBoost Target$197.00 ➝ $203.00Low
5/31/2023CitigroupLower Target$218.00 ➝ $200.00Low
5/25/2023KeyCorpLower Target$200.00 ➝ $185.00Low
5/22/2023UBS GroupLower Target$190.00 ➝ $175.00Low
3/21/2023OppenheimerReiterated RatingOutperform$225.00Low
3/17/2023Truist FinancialReiterated RatingBuy ➝ Hold$205.00 ➝ $195.00Low
3/6/2023TD CowenBoost TargetMarket Perform$184.00 ➝ $189.00Low
3/3/2023KeyCorpLower TargetOverweight$210.00 ➝ $200.00Low
3/2/2023Piper SandlerBoost Target$204.00 ➝ $212.00Low
3/2/2023Truist FinancialLower TargetBuy$225.00 ➝ $205.00Low
3/2/2023Needham & Company LLCReiterated RatingBuy$220.00Low
3/2/2023JMP SecuritiesBoost TargetMarket Outperform$215.00 ➝ $230.00Low
3/2/2023BarclaysLower TargetOverweight$205.00 ➝ $197.00Low
3/1/2023CitigroupLower TargetBuy$213.00 ➝ $200.00Low
2/27/2023Robert W. BairdLower TargetOutperform$233.00 ➝ $223.00Low
2/23/2023GuggenheimDowngradeBuy ➝ NeutralLow
1/17/2023Raymond JamesLower TargetOutperform$215.00 ➝ $200.00Low
1/12/2023OppenheimerLower TargetOutperform$250.00 ➝ $225.00Low
1/9/2023Piper SandlerLower TargetOverweight$220.00 ➝ $204.00Low
1/6/2023Morgan StanleyLower TargetEqual Weight$190.00 ➝ $181.00Low
1/4/2023BarclaysUpgradeEqual Weight ➝ Overweight$205.00Low
12/20/2022UBS GroupLower TargetNeutral$200.00 ➝ $190.00Low
12/6/2022CowenInitiated CoverageMarket Perform$184.00Low
12/6/2022CowenInitiated CoverageMarket PerformLow
12/5/2022KeyCorpLower TargetOverweight$220.00 ➝ $210.00Low
12/2/2022GuggenheimBoost Target$232.00Low
12/2/2022Raymond JamesLower TargetOutperform$225.00 ➝ $215.00Low
12/2/2022Needham & Company LLCBoost TargetBuy$205.00 ➝ $220.00Low
12/2/2022SVB LeerinkLower TargetOutperform$242.00 ➝ $233.00Low
11/28/2022UBS GroupBoost TargetNeutral$195.00Low
10/31/2022Robert W. BairdLower Target$250.00 ➝ $233.00Low
10/31/2022Wells Fargo & CompanyInitiated CoverageEqual Weight$180.00Low
10/28/2022The Goldman Sachs GroupLower TargetBuy$235.00 ➝ $205.00Low
10/20/2022Piper SandlerLower TargetOverweight$245.00 ➝ $220.00Low
10/19/2022JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$225.00 ➝ $170.00Low
9/15/2022KeyCorpInitiated CoverageOverweight$220.00Low
9/6/2022GuggenheimLower Target$230.00Low
9/6/2022The Goldman Sachs GroupLower Target$235.00Low
9/1/2022Raymond JamesBoost TargetOutperform$205.00 ➝ $225.00Low
9/1/2022Canaccord Genuity GroupLower Target$200.00 ➝ $185.00Low
9/1/2022Royal Bank of CanadaLower TargetOutperform$250.00 ➝ $225.00Low
9/1/2022Robert W. BairdLower TargetOutperform$267.00 ➝ $250.00Low
9/1/2022JMP SecuritiesLower TargetMarket Outperform$240.00 ➝ $215.00Low
9/1/2022UBS GroupLower TargetNeutral$220.00 ➝ $185.00Low
9/1/2022BarclaysLower TargetEqual Weight$222.00 ➝ $205.00Low
9/1/2022Piper SandlerLower TargetOverweight$275.00 ➝ $245.00Low
9/1/2022SVB LeerinkLower TargetOutperform$268.00 ➝ $242.00Low
8/23/2022BarclaysBoost TargetEqual Weight$195.00 ➝ $222.00Low
8/16/2022Morgan StanleyBoost TargetEqual Weight$175.00 ➝ $190.00Low
7/27/2022OppenheimerReiterated RatingInitiatesLow
7/26/2022OppenheimerInitiated CoverageOutperform$250.00Low
7/18/2022Piper SandlerLower TargetOverweight$290.00 ➝ $275.00Low
6/29/2022Stifel NicolausBoost TargetBuy$220.00 ➝ $240.00Low
6/23/2022The Goldman Sachs GroupInitiated CoverageBuy$253.00Low
6/21/2022GuggenheimReiterated RatingBuy$252.00Low
6/3/2022CitigroupBoost Target$232.00Low
6/2/2022Truist FinancialLower TargetBuy$275.00 ➝ $225.00High
6/2/2022Canaccord Genuity GroupLower TargetHold ➝ Hold$300.00 ➝ $200.00High
6/2/2022Raymond JamesLower Target$260.00 ➝ $205.00High
6/2/2022JMP SecuritiesLower TargetMarket Outperform$265.00 ➝ $240.00High
6/2/2022Needham & Company LLCLower TargetBuy$270.00 ➝ $205.00High
5/24/2022BarclaysLower TargetEqual Weight$237.00 ➝ $195.00Medium
3/14/2022SVB LeerinkReiterated RatingBuy$268.00Low
3/10/2022JMP SecuritiesLower TargetMarket Outperform$345.00 ➝ $265.00Medium
3/3/2022SVB LeerinkLower TargetOutperform$282.00 ➝ $268.00High
3/3/2022GuggenheimLower TargetBuy$350.00 ➝ $255.00High
3/3/2022Bank of AmericaDowngradeBuy ➝ Neutral$300.00 ➝ $220.00High
3/3/2022Needham & Company LLCLower TargetBuy$327.00 ➝ $270.00High
3/3/2022Robert W. BairdLower Target$303.00 ➝ $288.00High
3/3/2022Raymond JamesLower TargetOutperform$335.00 ➝ $260.00High
3/3/2022Royal Bank of CanadaLower TargetOutperform$400.00 ➝ $300.00High
3/3/2022Piper SandlerLower TargetOverweight$300.00 ➝ $290.00High
3/1/2022CitigroupLower Target$349.00 ➝ $278.00Medium
2/28/2022BarclaysLower TargetEqual Weight$310.00 ➝ $260.00Medium
1/28/2022Truist FinancialInitiated CoverageBuy$275.00High
1/10/2022Piper SandlerLower Target$360.00 ➝ $300.00High
1/7/2022StephensDowngradeOverweight ➝ Equal Weight$275.00High
1/6/2022SVB LeerinkUpgradeMarket Perform ➝ Outperform$282.00Low
12/16/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight$330.00 ➝ $280.00High
12/13/2021CitigroupLower TargetBuy ➝ Buy$356.00 ➝ $349.00Low
12/2/2021Needham & Company LLCLower TargetBuy$385.00 ➝ $327.00High
12/2/2021Robert W. BairdLower TargetOutperform$349.00 ➝ $310.00High
12/2/2021UBS GroupLower TargetIn-Line ➝ Neutral$320.00 ➝ $290.00High
12/2/2021SVB LeerinkLower TargetMarket Perform$296.00 ➝ $282.00High
10/20/2021William BlairReiterated RatingBuyLow
10/1/2021Stifel NicolausInitiated CoverageBuy$335.00Low
9/2/2021Robert W. BairdBoost TargetOutperform$340.00 ➝ $349.00High
9/2/2021Bank of AmericaBoost TargetBuy$340.00 ➝ $350.00High
9/2/2021JMP SecuritiesBoost TargetPositive ➝ Outperform$320.00 ➝ $345.00High
9/2/2021UBS GroupBoost TargetNeutral$270.00 ➝ $320.00High
9/2/2021Needham & Company LLCBoost TargetBuy$336.00 ➝ $385.00High
9/2/2021SVB LeerinkBoost TargetMarket Perform$294.00 ➝ $296.00High
9/2/2021CitigroupBoost TargetBuy$340.00 ➝ $356.00High
8/31/2021GuggenheimReiterated RatingBuyLow
7/21/2021CowenInitiated CoverageOutperform$400.00Low
7/21/2021Royal Bank of CanadaInitiated CoverageOutperform$400.00Low
5/28/2021Piper SandlerBoost TargetOverweight$350.00 ➝ $360.00High
5/28/2021Morgan StanleyBoost TargetOverweight$340.00 ➝ $350.00High
5/28/2021BarclaysBoost TargetEqual Weight$310.00 ➝ $320.00High
5/28/2021CitigroupBoost TargetBuy$335.00 ➝ $340.00High
3/31/2021Raymond JamesReiterated RatingBuyHigh
3/31/2021UBS GroupUpgradeSell ➝ Neutral$245.00 ➝ $250.00High
3/4/2021CitigroupBoost TargetBuy$320.00 ➝ $335.00Medium
3/3/2021Truist FinancialBoost Target$320.00 ➝ $355.00High
3/3/2021DA DavidsonBoost Target$325.00 ➝ $350.00High
3/3/2021Morgan StanleyBoost TargetOverweight$332.00 ➝ $340.00High
3/3/2021Needham & Company LLCBoost TargetBuy$327.00 ➝ $336.00High
3/3/2021SVB LeerinkBoost TargetMarket Perform$282.00 ➝ $294.00High
3/3/2021Piper SandlerBoost TargetOverweight$340.00 ➝ $350.00High
2/17/2021KeyCorpBoost TargetOverweight$332.00 ➝ $353.00Low
1/11/2021Piper SandlerBoost Target$310.00 ➝ $340.00Low
1/7/2021KeyCorpInitiated CoverageOverweight$332.00N/A
12/9/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$297.00Medium
12/2/2020DA DavidsonReiterated RatingBuyLow
12/2/2020Morgan StanleyBoost TargetOverweight$323.00 ➝ $332.00High
12/2/2020JMP SecuritiesBoost TargetPositive ➝ Outperform$293.00 ➝ $305.00High
12/2/2020Needham & Company LLCBoost TargetBuy$310.00 ➝ $327.00High
10/26/2020Raymond JamesBoost TargetOutperform$285.00 ➝ $335.00Low
10/13/2020UBS GroupInitiated CoverageSell$225.00Medium
8/31/2020Morgan StanleyBoost TargetOverweight$253.00 ➝ $323.00Medium
8/28/2020FBN SecuritiesBoost TargetPositive ➝ Outperform$300.00 ➝ $310.00Low
8/28/2020Truist FinancialBoost Target$222.00 ➝ $320.00Low
8/28/2020JMP SecuritiesBoost Target$210.00 ➝ $293.00Low
8/28/2020JPMorgan Chase & Co.Boost TargetNeutral$200.00 ➝ $297.00High
8/28/2020Bank of AmericaBoost TargetBuy$230.00 ➝ $302.00Medium
8/28/2020DA DavidsonBoost TargetBuy$235.00 ➝ $325.00High
8/28/2020Stifel NicolausBoost TargetBuy$225.00 ➝ $300.00High
8/28/2020SVB LeerinkBoost TargetMarket Perform$167.00 ➝ $282.00High
8/28/2020Raymond JamesBoost TargetOutperform$230.00 ➝ $285.00High
8/28/2020Needham & Company LLCBoost TargetPositive ➝ Buy$235.00 ➝ $310.00High
8/28/2020StephensBoost TargetOverweight$290.00 ➝ $325.00High
8/28/2020Piper SandlerBoost TargetOverweight$220.00 ➝ $310.00High
8/26/2020BarclaysBoost TargetEqual Weight$200.00 ➝ $261.00Low
8/20/2020GuggenheimBoost TargetBuy$225.00 ➝ $300.00Medium
8/14/2020Morgan StanleyBoost TargetOverweight$230.00 ➝ $253.00Low
7/23/2020FBN SecuritiesInitiated CoverageOutperform$300.00High
7/6/2020StephensInitiated CoverageOverweight$290.00Low
6/29/2020The Goldman Sachs GroupBoost Target$197.00 ➝ $228.00Medium
6/22/2020Robert W. BairdBoost TargetOutperform$242.00 ➝ $256.00High
6/8/2020Needham & Company LLCInitiated CoverageBuy$235.00Medium
6/8/2020CitigroupInitiated CoverageBuy$265.00High
6/1/2020William BlairReiterated RatingBuyMedium
5/29/2020CfraBoost TargetHold$164.00 ➝ $208.00High
5/29/2020SunTrust BanksBoost Target$167.00 ➝ $222.00High
5/29/2020Raymond JamesReiterated RatingOutperform$180.00 ➝ $230.00High
5/29/2020DA DavidsonBoost TargetBuy$200.00 ➝ $235.00High
5/29/2020Morgan StanleyBoost TargetOverweight$226.00 ➝ $230.00High
5/29/2020Needham & Company LLCBoost TargetBuy$187.00 ➝ $235.00High
5/29/2020SVB LeerinkBoost TargetMarket Perform$166.00 ➝ $167.00High
5/29/2020Piper SandlerBoost TargetOverweight$180.00 ➝ $220.00High
5/27/2020BarclaysBoost TargetEqual Weight$176.00 ➝ $200.00High
5/22/2020Morgan StanleyBoost TargetOverweight$175.00 ➝ $226.00High
4/13/2020SVB LeerinkInitiated CoverageMarket Perform$166.00Low
4/13/2020Needham & Company LLCReiterated RatingBuy$187.00Medium
3/31/2020Piper SandlerLower TargetOverweight$188.00 ➝ $180.00Medium
3/26/2020SunTrust BanksLower TargetBuy$175.00 ➝ $167.00High
3/25/2020Morgan StanleyLower TargetOverweight$176.00 ➝ $175.00High
3/4/2020CfraLower TargetHold$185.00 ➝ $164.00Medium
3/4/2020Robert W. BairdBoost TargetOutperform$184.00 ➝ $190.00High
3/4/2020Bank of AmericaReiterated RatingBuy$192.00 ➝ $180.00Medium
3/4/2020Stifel NicolausLower TargetBuy$185.00 ➝ $170.00High
3/4/2020Morgan StanleyBoost TargetOverweight$175.00 ➝ $176.00High
2/18/2020Robert W. BairdInitiated CoverageOutperform$184.00Medium
2/14/2020Piper SandlerInitiated CoverageOverweight$188.00High
1/13/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$160.00 ➝ $175.00Low
1/7/2020Deutsche Bank AktiengesellschaftLower TargetHold$160.00 ➝ $150.00Medium
11/28/2019Evercore ISIReiterated RatingHold$170.00Low
11/27/2019StephensReiterated RatingBuy$185.00Medium
11/27/2019BarclaysBoost TargetEqual Weight$165.00 ➝ $176.00Medium
11/27/2019Morgan StanleyBoost TargetEqual Weight$150.00 ➝ $160.00Medium
11/25/2019Needham & Company LLCReiterated RatingBuy$187.00High
10/3/2019Morgan StanleyLower TargetEqual Weight$154.00 ➝ $150.00High
9/27/2019SunTrust BanksSet TargetBuy$180.00Medium
9/26/2019Raymond JamesUpgradeMarket Perform ➝ Outperform$180.00Medium
9/23/2019Morgan StanleyBoost TargetEqual Weight$152.00 ➝ $154.00Low
8/28/2019StephensBoost TargetOverweight$155.00 ➝ $185.00High
8/28/2019SunTrust BanksBoost TargetBuy$150.00 ➝ $180.00High
8/28/2019DA DavidsonBoost TargetBuy$165.00 ➝ $200.00High
8/28/2019JMP SecuritiesBoost TargetMarket Outperform$153.00 ➝ $172.00High
8/28/2019BarclaysBoost TargetEqual Weight$151.00 ➝ $165.00High
8/28/2019KeyCorpBoost TargetOverweight$172.00 ➝ $190.00High
8/28/2019GuggenheimBoost TargetBuy$154.00 ➝ $180.00High
8/28/2019Needham & Company LLCBoost TargetBuy$150.00 ➝ $187.00High
8/28/2019JPMorgan Chase & Co.Boost TargetNeutral$150.00 ➝ $183.00High
8/27/2019KeyCorpReiterated RatingBuyHigh
8/23/2019Stifel NicolausBoost TargetBuy$155.00 ➝ $175.00Low
6/10/2019Bank of AmericaBoost TargetBuy$160.00 ➝ $192.00Medium
6/7/2019The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$151.00Medium
5/30/2019JPMorgan Chase & Co.Boost TargetNeutral$103.00 ➝ $150.00High
5/30/2019Deutsche Bank AktiengesellschaftBoost TargetHold$115.00 ➝ $135.00High
5/30/2019BarclaysBoost TargetEqual Weight$144.00 ➝ $151.00High
5/30/2019JMP SecuritiesBoost TargetMarket Outperform$122.00 ➝ $153.00High
5/30/2019Bank of AmericaBoost TargetBuy$140.00 ➝ $160.00Low
5/30/2019SunTrust BanksBoost TargetBuy$150.00High
5/30/2019DA DavidsonBoost TargetBuy$165.00High
5/30/2019KeyCorpBoost TargetOverweight$133.00 ➝ $172.00High
5/30/2019StephensUpgradeEqual ➝ Overweight$130.00 ➝ $155.00High
5/24/2019Morgan StanleyDowngradeOverweight ➝ Equal Weight$126.00 ➝ $144.00Low
5/22/2019Stifel NicolausBoost TargetBuy$130.00 ➝ $150.00Low
(Data available from 4/18/2019 forward)

News Sentiment Rating

0.97 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 32 very positive mentions
  • 32 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
9/21/2023
  • 24 very positive mentions
  • 13 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
10/21/2023
  • 4 very positive mentions
  • 20 positive mentions
  • 6 negative mentions
  • 0 very negative mentions
11/20/2023
  • 31 very positive mentions
  • 28 positive mentions
  • 5 negative mentions
  • 2 very negative mentions
12/20/2023
  • 22 very positive mentions
  • 19 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
1/19/2024
  • 33 very positive mentions
  • 26 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
2/18/2024
  • 39 very positive mentions
  • 28 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
3/19/2024
  • 26 very positive mentions
  • 27 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/18/2024

Current Sentiment

  • 26 very positive mentions
  • 27 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Veeva Systems logo
Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process. In addition, it offers professional and support services, including implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; data migration and systems integrations technical consulting services; training on its solutions; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
Read More

Today's Range

Now: $199.52
Low: $197.56
High: $201.62

50 Day Range

MA: $221.54
Low: $199.18
High: $234.79

52 Week Range

Now: $199.52
Low: $160.21
High: $236.90

Volume

850,277 shs

Average Volume

988,512 shs

Market Capitalization

$32.19 billion

P/E Ratio

61.96

Dividend Yield

N/A

Beta

0.74

Frequently Asked Questions

What sell-side analysts currently cover shares of Veeva Systems?

The following Wall Street sell-side analysts have issued stock ratings on Veeva Systems in the last year: Bank of America Co., Barclays PLC, Canaccord Genuity Group Inc., Citigroup Inc., Guggenheim, Jefferies Financial Group Inc., JPMorgan Chase & Co., KeyCorp, Morgan Stanley, Needham & Company LLC, Oppenheimer Holdings Inc., Piper Sandler, Raymond James, Robert W. Baird, Royal Bank of Canada, Stifel Nicolaus, StockNews.com, The Goldman Sachs Group, Inc., Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for VEEV.

What is the current price target for Veeva Systems?

20 Wall Street analysts have set twelve-month price targets for Veeva Systems in the last year. Their average twelve-month price target is $234.90, suggesting a possible upside of 17.7%. Jefferies Financial Group Inc. has the highest price target set, predicting VEEV will reach $270.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $160.00 for Veeva Systems in the next year.
View the latest price targets for VEEV.

What is the current consensus analyst rating for Veeva Systems?

Veeva Systems currently has 1 sell rating, 5 hold ratings and 14 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for VEEV.

What other companies compete with Veeva Systems?

Other companies that are similar to Veeva Systems include HubSpot, Cloudflare, ANSYS, MongoDB and Datadog. Learn More about companies similar to Veeva Systems.

How do I contact Veeva Systems' investor relations team?

Veeva Systems' physical mailing address is 4280 HACIENDA DRIVE, PLEASANTON CA, 94588. The technology company's listed phone number is (925) 452-6500 and its investor relations email address is [email protected]. The official website for Veeva Systems is www.veeva.com. Learn More about contacing Veeva Systems investor relations.